Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis

OBJECTIVE: To observe the efficacy of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) for pulmonary alveolar proteinosis (PAP). MATERIALS AND METHODS: A total of 55 patients with PAP were screened at Shanghai Pulmonary Hospital between May 2014 and May 2018. Among these...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fen, Weng, Dong, Su, Yiliang, Yin, Chengsheng, Shen, Li, Zhang, Yuan, Zhou, Ying, Li, Qiuhong, Hu, Yang, Li, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941258/
https://www.ncbi.nlm.nih.gov/pubmed/31898493
http://dx.doi.org/10.1186/s12931-019-1261-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941258/
https://www.ncbi.nlm.nih.gov/pubmed/31898493
http://dx.doi.org/10.1186/s12931-019-1261-1

Ejemplares similares